Connectyx Reports Fiscal Year 2020 Financial Results
March 09, 2021 10:24 ET
|
Connectyx Technologies Holdings Group, Inc
Biotechnology Company Issues Highlights and Subsequent Events Boca Raton, Fla, March 09, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the...
Connectyx Announces Key Biotech Industry Veterans to Management Team
February 11, 2021 10:50 ET
|
Connectyx Technologies Holdings Group, Inc
Expertise in Clinical Development, Regulatory Affairs and Manufacturing Represented Boca Raton, Fla, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX)...
Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma
October 16, 2020 11:00 ET
|
Connectyx Technologies Holdings Group, Inc
Boca Raton, FL, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...
Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies
October 09, 2020 09:30 ET
|
Connectyx Technologies Holdings Group, Inc
Boca Raton, FL, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...
Connectyx Technologies Holdings Group, Inc. Announces Strategic Relationship with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies
August 27, 2020 09:30 ET
|
Connectyx Technologies Holdings Group, Inc
Company to Acquire Worldwide Rights for Development of IMT504 Boca Raton, FL, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the...
Connectyx Welcomes Dr. Michael Grace and Dr. Ronald Bordens to the Company’s Scientific Advisory Board
May 08, 2020 09:30 ET
|
Connectyx Technologies Holdings Group, Inc
Boca Raton, FL, May 08, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a global biomedical company that focuses on the orphan drug...
Connectyx Technologies Issues Shareholder Update
May 01, 2020 09:30 ET
|
Connectyx Technologies Holdings Group, Inc
BOCA RATON, FL, May 01, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC PINK: CTYX), a global biomedical company issues the following update to shareholders. Dear...
Connectyx Technologies Holdings Group Returns to OTC Current Status
April 13, 2020 09:30 ET
|
Connectyx Technologies Holdings Group, Inc
More than $350,000 of Convertible Debt Eliminated BOCA RATON, FL, April 13, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group (OTC PINK: CTYX) has filed all required annual reports...